Cannabinoids for Chronic Pain
Once you're logged in, please select the "REGISTER" tab to process your payment and complete your registration.
Once you register for the course, you will have 180 days (approximately 6 months) from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
- List the FDA-approved cannabinoid-based medications.
- Determine when cannabinoids might be considered for a patient with chronic pain.
- Weigh the risks and benefits of cannabinoid therapy.
- Identify Iowa guidelines and regulations pertaining to the use of cannabinoid therapy.
Jolene Smith, DO, DABA, DABA-PM
Pain Medicine Physician, Pain Specialists of Iowa
Karry Smith, PhD, MPH
Founder and Medical Writer, Periphas Science Group
Relevant to the content of this educational activity, Dr. Karry Smith indicated she is a consultant for MedPharm Iowa and Dr. Jolene Smith indicated she is a consultant for Boston Scientific.
Copyright: All rights reserved. By viewing this activity, participants agree to abide by copyright and trademark laws, intellectual property rights, and all other applicable laws of the United States of America. No part of the syllabus may be used or reproduced in any manner whatsoever without written permission, except in the case of brief quotations embodied in articles or reviews.
Internet CME Policy: The Office of Continuing Medical Education (CME) at Des Moines University (DMU) is committed to protecting the privacy of its customers. DMU CME maintains its Internet site as an information resource and service for health professionals. DMU CME will keep your personal and credit information confidential when you participate in an Internet based program. Your information will never be given to anyone outside of the DMU CME program. DMU CME collects only the information necessary to provide you with the services that you request.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 0.75 AOA Category 1B
- 0.75 AMA PRA Category 1 Credits™
- 0.75 CE Contact Hours